Increase in Prevalence of Musculoskeletal Disorder will bolster the Demand for Foot and Ankle Allograft Market

As per the National Institute of Health (NIH) in the year 2010 study, Allograft tissue has been used for more than two centuries in the repair of musculoskeletal injuries and defects. More than 150,000 procedures are performed each year in the U.S. alone, ten times the number of organ transplants. The increased prevalence of musculoskeletal injuries and defects further impacts the demand of foot and ankle allograft. Consequently, the global foot and ankle allograft market is estimated to increase rapidly in the near future.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-foot-ankle-allograft-market

Data Bridge Market Research analyses that the foot and ankle allograft market is expected to grow at a CAGR of 9.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,349.49 million by 2029. The expanse of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors including the financing arrangements and structure of the organization of the health system. Growing healthcare expenditure significantly and positively affects the development and advancement of allografts. Hence, massive health care expenditure is a favorable factor for the growth of the foot and ankle allografts market

Foot and Ankle Allografts Market

Surge in Strategic Initiatives by Market Players is expected to drive the Market's Growth Rate

The strategic initiatives such as acquisition, product launches, partnership, contract agreements, and participation in conferences provide an opportunity to flourish their customer base geographically. For instance, Metalogix announced the approval to launch the revolution external plating system that will be used to treat foot and ankle in adults. This has increased the company’s product portfolio and sales. Moreover, through such initiative strategies, both the companies can expand their reach through new geographic or industry markets, access to new products or services, or new types of customers. Both the market players open the door to additional or new resources such as technology and talent. An increase in strategic initiatives by major market players has increased the demand for foot and ankle allografts and is expected to increase the market growth.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020(Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), Surgery Type (Orthopedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon and Ligament Repair, Wound Care), Procedure (Midfoot Procedures, Hindfoot Procedures) End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Academic and Research Institutes, Other End Users)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered


CONMED Corporation (U.S.), Wright Medical Group N.V. (U.S.), Arthrex (U.S.), Integra LifeSciences (U.S.), Smith+Nephew (UK), Zimmer Biomet (U.S.), AlloSource (U.S.), Amniox Medical, Inc. (U.S.), RTI Surgical Holdings, Inc. (U.S.), JRF Ortho (U.S.), Bone Bank Allografts (U.S.),  Smith & Nephew. (UK), Paragon 28 (U.S.), Bioventus, (U.S.), NVision Biomedical Technologies (U.S.), DePuy Synthes Companies (U.S.) among others            

Data Points Covered in Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The foot and ankle allografts market is categorized based on product type, surgery type, procedure and end user.

  • On the basis of product type, the global foot and ankle allografts market is segmented into allograft wedges, allograft tendons, allograft, acellular dermal matrix, cartilage allograft matrix, skin allografts, and amniotic membranes. In 2022, allograft wedges segment in global foot and ankle allografts market with the highest CAGR of 13.2 % in the forecast period of 2022 to 2029. The allograft wedges segment in the global foot and ankle allografts market is expected to grow with the increasing advancement in the technology.
  • On the basis of surgery type, the global foot and ankle allografts market is segmented into orthopedic reconstruction, cartilage restoration, soft tissue tendon and ligament repair and wound care. In 2022, orthopedic reconstruction segment in global foot and ankle allografts market with the highest CAGR of 10.9%

The orthopedic reconstruction segment in global foot and ankle allografts market

In 2022, orthopedic reconstruction segment in global foot and ankle allografts market with the highest CAGR of 10.9% in the forecast period of 2022 to 2029. The orthopedic reconstruction segment in the global foot and ankle allografts market is expected to grow with the increasing product launches and rising research and developement activities by major market players.

  • On the basis of procedure, the global foot and ankle allografts market is segmented into midfoot procedures and hind-foot procedures. In 2022, midfoot procedures segment in global foot and ankle allografts market is growing at the highest CAGR of 10.2 %

The midfoot procedures segment in global foot and ankle allografts market

In 2022, midfoot procedures segment in global foot and ankle allografts market is growing at the highest CAGR of 10.2 % in the forecast period of 2022 to 2029. In 2022, midfoot procedures segment in global foot and ankle allografts market is expected to grow with the increasing use of foot and ankle allografts and increasing chronic disease globally.

  • On the basis of end user, the global foot and ankle allografts market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, academic and research institutes and other end users. In 2022, hospital segment, the global foot and ankle allografts market, growing at the highest CAGR of 10.2 % in the forecast period of 2022 to 2029. In 2022, the hospital segment in the global foot and ankle allografts market is expected to grow with the increasing patient population in hospitals.

Major Players

Data Bridge Market Research recognizes the following companies as the major foot and ankle allograft market players in foot and ankle allograft market are CONMED Corporation (U.S.), Wright Medical Group N.V. (U.S.), Arthrex (U.S.), Integra LifeSciences (U.S.), Smith+Nephew (UK), Zimmer Biomet (U.S.), AlloSource (U.S.), Amniox Medical, Inc. (U.S.), RTI Surgical Holdings, Inc. (U.S.), JRF Ortho (U.S.), Bone Bank Allografts (U.S.),  Smith & Nephew. (UK), Paragon 28 (U.S.), Bioventus, (U.S.), NVision Biomedical Technologies (U.S.), DePuy Synthes Companies (U.S.) among others.

global-foot-ankle-allograft-market

Market Development

  • In July 2021, Integra LifeSciences announced its SurgiMend Collagen Matrix for Soft Tissue Reconstruction had received an Innovative Technology contract from Vizient, Inc. This has increased the company’s sales and distribution channel.
  • In October 2020, WishBone Medical, Inc., a leader in paediatric orthopaedic medical devices, announced today that their Smart Correction® External Fixation System, which includes hexapod external fixator hardware and proprietary planning software, has received FDA 510(k) clearance. Since 2009, the System has been used in facilities throughout Asia and Europe. It has a proven track record of higher accuracy [compared to Ilizarov fixators] and a design that allows surgeons to perform efficient, precise calculations with unrestricted strut placement.
  • In October 2021, AlloSource®, one of the largest allograft providers in the United States, has announced the launch of AlloMend® Extra-Large (XL) Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line.
  • In January 2021, Direct Biologics, LLC, an industry leader in extracellular vesicle technology, announced today that AmnioWrapTM placental-based sheet allografts are now available for clinical use. AmnioWrapTM is a one-of-a-kind tri-layer graft designed for use in acute and chronic wounds. The allograft contains a collagen extracellular matrix as well as a diverse set of regulatory proteins such as growth factors, cytokines, and chemokines – all of which are known key factors in healing and tissue regeneration.

Regional Analysis

Geographically, the countries covered in the foot and ankle allograft market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in foot and ankle allograft market during the forecast period

North America dominated the foot and ankle allograft market due to the rise in technological advancement to develop allografts. North America will continue to dominate the foot and ankle allograft market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increase in product offerings, the presence of key market players in the region, increased affordability, and an increase in demand for early diagnosis within this region.  

Global Foot and Ankle Allografts Market

Asia-Pacific is estimated to be the fastest growing region in foot and ankle allograft market

Asia-Pacific is expected to grow during the forecast period due to the increasing incidence of musculoskeletal disorder in this region. In addition to this, the rising level of geriatric population is expected to propel the market's growth rate in this region.

COVID-19 Impact Analysis

The outbreak of COVID-19 largely impacted the foot and ankle allograft market.  The pandemic led to substantial upsurge in demand for the lungs allografts across the globe. However, the foot and ankle allograft on the other hand, witnessed huge decline. The decline in the foot and ankle allograft can be attributed to the lesser focus towards other medical emergencies during the pandemic. As the admission of COVID-19 patients in hospitals increased, the transplantation procedure of cells, tissues or organs was canceled or postponed massively to reserve hospital beds and patient care staff to COVID-19 patient care. Moreover, the imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to emergence of various challenges such as the denied services, halt of various operations, cancelled or postponed elective surgeries, stifling business growth, suspensions of new developments and even increasing skin injuries in COVID-19 medical care providers, further limiting the industry's expansion.

However, there has been a decline in COVID-19 disease worldwide, which will result in increased wound care services. Moreover, the restrictions and measures are likely to relax, which will help market to witness a slight increment, as the manufacturers are focusing on various developments and innovations, market trends, and other expansion strategies. Thus, the foot and ankle allograft market will grow at an accelerated pace post COVID-19.

For more detailed information about the foot and ankle allograft market report, click here – https://www.databridgemarketresearch.com/reports/global-foot-ankle-allograft-market